THE BioMed Co., Ltd. (KOSDAQ:214610)

Rover Group Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	29,662	60,853	80,681	87,860	166,501	204,207
Market Cap Growth	-64.81%	-24.58%	-8.17%	-47.23%	-18.46%	148.32%
Enterprise Value	50,377	73,659	100,389	97,164	156,031	213,436
Last Close Price	5760.00	13970.00	18520.00	30812.16	58414.73	72216.01
PS Ratio	6.46	13.12	15.03	5.45	5.50	4.47
PB Ratio	1.28	2.35	2.22	4.98	3.19	3.65
P/TBV Ratio	1.78	3.14	2.61	5.32	3.27	3.71
EV/Sales Ratio	10.97	15.87	18.70	6.03	5.15	4.67
EV/EBITDA Ratio	-	-	-	-	-	40.72
EV/EBIT Ratio	-	-	-	-	-	61.59
Debt / Equity Ratio	0.91	0.83	0.38	1.32	0.42	0.12
Debt / EBITDA Ratio	-	-	-	-	-	1.28
Asset Turnover	0.09	0.08	0.09	0.22	0.38	0.95
Inventory Turnover	0.87	1.17	0.85	0.92	0.82	2.03
Quick Ratio	0.12	1.09	1.42	0.57	4.02	3.93
Current Ratio	0.96	1.89	2.70	1.33	5.94	6.46
Return on Equity (ROE)	-91.78%	-90.33%	-95.59%	-111.40%	-19.57%	-20.29%
Return on Assets (ROA)	-22.96%	-23.72%	-21.02%	-22.17%	-8.50%	4.51%
Return on Capital (ROIC)	-27.36%	-28.23%	-27.48%	-28.10%	-9.90%	5.24%
Return on Capital Employed (ROCE)	-	-	-	-	-	5.60%
Earnings Yield	-93.43%	-50.69%	-31.95%	-44.27%	-6.35%	-2.83%
FCF Yield	-58.02%	-19.15%	-14.56%	-17.79%	-6.87%	-11.97%
Buyback Yield / Dilution	-51.26%	-76.24%	-12.70%	-0.19%	-25.24%	-22.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.